The existing tau tracers are small molecules and although we think of them as specific to tau itself, their specificity is actually based on the structure of the tau β-sheet that is adopted when tau forms the different kinds of fibrils in AD or other tauopathies. Here, MAPT is linked to Alzheimer disease.